Diclofenac topical - Novartis

Drug Profile

Diclofenac topical - Novartis

Alternative Names: Diclofenac sodium gel 1% - Novartis; Voltaren Gel

Latest Information Update: 20 Sep 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Novartis
  • Developer Endo Pharmaceuticals; Novartis
  • Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Arachidonic acid inhibitors; Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Musculoskeletal pain
  • No development reported Acute pain

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 20 Sep 2017 No recent reports on development identified - Phase-III for Acute pain (in patients with acute blunt soft tissue injuries/contusions) in Germany and USA (Topical)
  • 24 Mar 2016 First generic equivalent is available in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top